Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay

Blood

Volumn 92, Issue 1, 1998, Pages 53-58

  Chatlynne, Louise G ^a   Lapps, William ^b   Handy, Michael ^b   Huang, Yao Q ^b   Masood, Rizwan ^b   Hamilton, Ann S ^b   Said, Jonathan W ^b   Koeffler, H P ^b   Kaplan, Mark H ^b   Friedman Kien, Alvin ^b   Gill, Parkash S ^b   Whitman, James E ^b   Ablashi, Dharam V ^b  

^a Advanced Biotechnologies Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY TITER; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; KAPOSI SARCOMA; PRIORITY JOURNAL; SEROPREVALENCE; SERUM;

EID: 17144449982     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.1.53.413k30_53_58     Document Type: Article

References (24)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of a herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 265:1865, 1994
2. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D: Lytic growth of Kaposi's sarcoma associated herpesvirus (human herpes 8) in culture. Nat Med 2:342, 1996
3. Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, Knowles DM, Cesarman E: Establishment and characterization of a body cavity based lymphoma cell line (BC-3) harboring Kaposi's sarcoma- associated herpesvirus (KSHV/HHV-8) in absence of Epstein-Barr Virus. Blood 88:2648, 1996
4. Said JW, Chien K, Takeuchi S, Tasaka T, Asou H, Cho S, de Vos S, Cesarman E, Knowles DM, Koeffler HP: Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) in primary effusion lymphoma: Ultrastructural demonstration of herpesvirus lymphoma cells. Blood 87:4937, 1996
5. Ablashi DV, Chatlynne LG, Lapps W, Hoekzema DT, Masood R, Kramarsky B, Kaplan M, Gill P, Friedman-Kien AE, Said J, Koeffler P, Whitman JE: Human herpesvirus-8: Epidemiology and characterization of virus form KS-1 cell line. 1st National AIDS Malignancy Conference, Bethesda Maryland. J Acquir Immune Defic Syndr Hum Retrovirol 14:A23, 1997 (abstract 29)
6. Lennette ET, Blackbourn DJ, Levy JA: Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348:858, 1996
7. Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R: The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high risk HIV-seronegative women, JAMA 277:478, 1997
8. Miller G, Rigsby MO, Heston L, Grogan E, Googan E, Sun R, Metroka D, Levy JA, Gao S-J, Chang Y, Moore PM: Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 334:1292, 1996
9. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Zeigler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore, PM: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2:925, 1996
10. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem J: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus); distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918, 1996
11. Simpson GR, Schulz TF, Whitby D, Cook PM, Bishoff C, Rainbow L, Howard MR, Gao SJ, Bohehzhy, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IVD, Weiss RA, Moore PS: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348:1133, 1996
12. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels R, Parry P, Chang Y, Moore PS: Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 335:223, 1996
13. Lin SF, Sun R, Heston L, Gradoville L, Shedd D, Hagland C, Rigsby M, Miller G: Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpes virus-encoded small viral capsid antigen. J Virol 71:3069, 1997
14. Ganem D: Human herpesvirus 8 and the biology of Kaposi's sarcoma. Semin Virol 7:325, 1996
15. Rickinson AB: Changing seroepidemiology of HHV-8. Lancet 348:1110, 1996
16. Chang Y, Moore PS: Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 5:215, 1996
17. Biggar RB: Cancer in acquired Immunodeficiency syndrome: An epidemiological assessment. Semin Oncol 17:251, 1990
18. Biggar RJ, Rosenberg PS, Coté T, Multistate AIDS/Cancer Match Study Group: Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Int J Cancer 68:754, 1996
19. Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo RC: AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223, 1989
20. Miles S, Rezai A, Salazar-Gonzales J: AIDS-Kaposi's sarcoma derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 87:4068, 1990
21. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Gallo R: Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma. Nature 371:674, 1994
22. Neipal F, Albrecht J, Fleckenstein B: Cell-homologous genes in the Kaposi's Sarcoma-associated rhadinovirus human herpesvirus 8:-Determinants of its pathogenicity? J Virol 71:4187, 1997
23. Miller G: Epstein-Barr virus: Pathology, pathogenesis, and medical aspects, in Fields BN, Kniple DM, Chanok RM, Hirsch MS, Melnick JL, Monath TP, Roizman B (eds): Virology, New York, NY, Raven, 1990, p 1921
24. Schmidt CW, Misko IS: The ecology and pathology of Epstein-Barr virus. Immunol Cell Biol 73:489, 1995